Stein C M, Lang C C, Nelson R, Brown M, Wood A J
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6602, USA.
Clin Pharmacol Ther. 1997 Oct;62(4):436-43. doi: 10.1016/S0009-9236(97)90122-3.
Attenuated vasodilation in response to the intra-arterial administration of the beta-adrenergic agonist isoproterenol (INN, isoprenaline), an endothelium-independent vasodilator, has previously been observed in normotensive black Americans. To determine whether this reflected a more generalized attenuation of responses to vasodilators, we compared forearm blood flow responses to the endothelium-dependent vasodilator methacholine and the endothelium-independent vasodilator sodium nitroprusside in young normotensive black men and white men.
Forearm blood flow responses to the intra-arterial administration of isoproterenol (10 to 400 ng/min), methacholine (0.25 to 8 micrograms/min), and sodium nitroprusside (0.25 to 8 micrograms/min) were measured with use of venous occlusion plethysmography in 11 normotensive black men (mean +/- SE age, 30.5 +/- 2.2 years) and nine normotensive white men (mean age, 28.0 +/- 3.2 years).
Baseline characteristics, including baseline forearm blood flow, were similar in the black and the white subjects. Vasodilation in response to isoproterenol, sodium nitroprusside, and methacholine was significantly attenuated in black subjects, resulting respectively in a 3.7-fold, 3.6-fold, and 5.0-fold increase in forearm blood flow in black subjects and a 7.5-fold, 5.2-fold, and 6.9-fold increase in forearm blood flow in white subjects (ANOVA; isoproterenol, p < 0.0001; sodium nitroprusside, p < 0.0001; methacholine, p = 0.01).
Our finding of attenuated nitric oxide-mediated vasodilation in response to methacholine and sodium nitroprusside in healthy black American men suggests that attenuated vasodilation in black subjects is a relatively generalized phenomenon, resulting in attenuated responses to multiple vasodilators that act through different receptor- and nonreceptor-mediated mechanisms.
先前在血压正常的美国黑人中观察到,对动脉内注射β-肾上腺素能激动剂异丙肾上腺素(国际非专利药品名称,异丙肾上腺素)(一种不依赖内皮的血管扩张剂)的血管舒张反应减弱。为了确定这是否反映了对血管扩张剂反应的更普遍减弱,我们比较了年轻血压正常的黑人男性和白人男性对依赖内皮的血管扩张剂乙酰甲胆碱和不依赖内皮的血管扩张剂硝普钠的前臂血流反应。
在11名血压正常的黑人男性(平均±标准误年龄,30.5±2.2岁)和9名血压正常的白人男性(平均年龄,28.0±3.2岁)中,使用静脉阻断体积描记法测量动脉内注射异丙肾上腺素(10至400 ng/min)、乙酰甲胆碱(0.25至8 μg/min)和硝普钠(0.25至8 μg/min)后的前臂血流反应。
黑人与白人受试者的基线特征相似,包括基线前臂血流。黑人受试者对异丙肾上腺素、硝普钠和乙酰甲胆碱的血管舒张反应明显减弱,导致黑人受试者前臂血流分别增加3.7倍、3.6倍和5.0倍,白人受试者前臂血流分别增加7.5倍、5.2倍和6.9倍(方差分析;异丙肾上腺素,p<0.0001;硝普钠,p<0.0001;乙酰甲胆碱,p = 0.01)。
我们发现健康的美国黑人男性对乙酰甲胆碱和硝普钠的一氧化氮介导的血管舒张反应减弱,这表明黑人受试者血管舒张减弱是一种相对普遍的现象,导致对多种通过不同受体和非受体介导机制起作用的血管扩张剂的反应减弱。